Human rhinovirus type B nucleic acid rapid detection system based on RT-RPA and CRISPR/Cas12a
The invention discloses a human rhinovirus type B nucleic acid rapid detection system based on RT-RPA (reverse transcription recombinase polymerase amplification) and CRISPR (clustered regularly interspaced short palindromic repeats)/Cas12a (CRISPR/Cas12a). The detection system comprises an RT-RPA i...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses a human rhinovirus type B nucleic acid rapid detection system based on RT-RPA (reverse transcription recombinase polymerase amplification) and CRISPR (clustered regularly interspaced short palindromic repeats)/Cas12a (CRISPR/Cas12a). The detection system comprises an RT-RPA isothermal amplification system and a CRISPR/Cas12a detection system, the RT-RPA isothermal amplification system comprises an RT-RPA primer pair designed on the basis of human rhinovirus B nucleic acid, and the RT-RPA primer pair comprises a forward primer and a reverse primer; the CRISPR/Cas12a detection system comprises crRNA (Ribonucleic Acid) which is designed on the basis of human rhinovirus type B nucleic acid. The CRISPR/Cas12a is adopted for detecting the nucleic acid sequence of the human rhinovirus B for the first time, and the method has the advantages of being high in sensitivity, high in specificity, short in consumed time, independent of large instruments and the like and is suitable for meeting the re |
---|